Perimeter Group Inc. (PRM) stock
PRMNYSEChemicals & Allied ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30224% above fair value
$29.63−1.04 (-3.39%)
Close on Nov 12, 2026Market cap $4.85BP/E 164.6Yield –
Perimeter EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Perimeter's EPS for the twelve months ending Sep 30, 2026 was $0.18, down 64.0% year over year. For fiscal 2025 it was -$1.37. The highest annual figure on record is $0.52 in fiscal 2022.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$1.37 | – |
| FY2024 | Dec 31, 2024 | -$0.04 | -109.8% |
| FY2023 | Dec 31, 2023 | $0.41 | -21.2% |
| FY2022 | Dec 31, 2022 | $0.52 | +13.0% |
| FY2020 | Dec 31, 2020 | $0.46 | – |
| FY2019 | Dec 31, 2019 | -$0.79 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.74 | – |
| Q2 FY2026 | Jun 30, 2026 | -$1.11 | – |
| Q1 FY2026 | Mar 31, 2026 | $0.44 | +22.2% |
| Q4 FY2025 | Dec 31, 2025 | -$0.89 | -190.8% |
| Q3 FY2025 | Sep 30, 2025 | -$0.62 | – |
| Q2 FY2025 | Jun 30, 2025 | -$0.22 | -257.1% |
| Q1 FY2025 | Mar 31, 2025 | $0.36 | – |
| Q4 FY2024 | Dec 31, 2024 | $0.98 | – |
| Q3 FY2024 | Sep 30, 2024 | -$0.61 | -608.3% |
| Q2 FY2024 | Jun 30, 2024 | $0.14 | -54.8% |
| Q1 FY2024 | Mar 31, 2024 | -$0.57 | -1050.0% |
| Q4 FY2023 | Dec 31, 2023 | -$0.08 | – |
| Q3 FY2023 | Sep 30, 2023 | $0.12 | -80.0% |
| Q2 FY2023 | Jun 30, 2023 | $0.31 | +520.0% |
| Q1 FY2023 | Mar 31, 2023 | $0.06 | -71.4% |
| Q4 FY2022 | Dec 31, 2022 | -$0.35 | -135.7% |
| Q3 FY2022 | Sep 30, 2022 | $0.60 | – |
| Q2 FY2022 | Jun 30, 2022 | $0.05 | – |
| Q1 FY2022 | Mar 31, 2022 | $0.21 | – |
| Q3 FY2021 | Sep 30, 2021 | $0.98 | -1.0% |
| Q2 FY2021 | Jun 30, 2021 | -$0.07 | – |
| Q1 FY2021 | Mar 31, 2021 | -$0.35 | – |
| Q4 FY2020 | Dec 31, 2020 | -$0.12 | – |
| Q3 FY2020 | Sep 30, 2020 | $0.99 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?